Stanex Drugs & Chemicals

Stanex Drugs & Chemicals is an Indian private pharmaceutical manufacturer focused on generic specialty injectables, including non-beta-lactam and beta-lactam sterile products, along with APIs, veterinary formulations, nutraceuticals, and contrast media. The company states that it began operations in veterinary products in 1995 and expanded into human injectables in 2004 with a manufacturing facility in Hyderabad, Telangana. Stanex markets and manufactures products in therapeutic areas such as cardiology, nephrology, anti-infectives, and gastrointestinal care, and also offers third-party manufacturing, contract development, regulatory support, and out-licensing for semi-regulated markets. Its product portfolio includes molecules such as streptokinase, heparin sodium, iron sucrose, caspofungin, tigecycline, vancomycin, ertapenem, omeprazole, pantoprazole, and gadolinium-based contrast agents. The business appears to be a commercial-stage generic pharma manufacturer rather than a clinical-stage biotech company.